Patent ID: 8436186

Claim:
A compound, which is one of the following compounds No. Structure and/or name “A1” 4-(2-Methyl-3-{4-[4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro- naphthalen-2-yl)thiazol-2-yl]piperidin-1-yl}propyl)- morpholine “A2” 1′-Ethyl-4[4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro- naphthalen-2-yl)thiazol-2-yl]-[1,3′]bipiperidinyl “A3” “A4” “A5” “A6” “A7” “A8” “A9” “A10” “A11 ” “A12” “A13” “A14” “A15” “A16” “A17” “A18” “A19” “A20” “A21” “A22” “A23” “A24” “A25” “A26” “A27” “A28” “A29” “A30” “A31” “A32” “A35” “A36” “A37” tert-Butyl (2-{4-[4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro- naphthalen-2-yl)thiazol-2-yl]piperidin-1-yl}ethyl)carbamate “A38” “A39” “A40” “A41” tert-Butyl (2-{4-[4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro- naphthalen-2-yl)thiazol-2-yl]piperidin-1-yl}ethyl)carbamate “A42” “A43” “A44” “A45” “A46” 3-Methoxypropyl 4-[4-(5,5,8,8-tetramethyl-5,6,7,8- tetrahydronaphthalen-2-yl)thiazol-2-yl]piperidine-1- carboxylate “A47” “A48” “A49” “A50” “A51” 2-Pyridin-4-yl-1-{4-[4-(5,5,8,8-tetramethyl-5,6,7,8-tetra- hydronaphthalen-2-yl)thiazol-2-yl]piperidin-1-yl}ethanone “A52” “A53” “A54” “A55” “A56” “A57” “A58” “A59” “A60” “A61” “A62” “A63” (S)-2-Amino-3-(3H-imidazol-4-yl)-1-{4-[4-(5,5,8,8- tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)thiazol-2-yl]- piperidin-1-yl}propan-1-one “A64” “A65” “A66” “A67” “A68” “A69” “A70” “A71” “A72” “A73” “A74” “A75” “A76” “A77” “A78” “A79” “A80” “A81” “A82” “A83” “B1” “B2” “B3” “B4” “B5” “B6” “B7” “B8” “B9” “B10” “B11” “B12” “B13” “B14” “B15” “B16” or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof.